Upcoming shows
Real News

NOW ON AIR
Now On Air

Story Time

1:00 am 6:00 am



Maga First News

Upcoming Shows

Join The MAGA Network on Discord

0 0

Mumps Vaccine Linked to Infertility in Adolescents, Young Adults – Report

It has been about five decades since the U.S. Food and Drug Administration (FDA) approved Merck’s first mumps vaccine.

The company began launching combination MMR (measles, mumps and rubella) vaccines in the 1970s.

Coincidentally—or not—an infertility crisis has been brewing over roughly the same time period, with dramatic declines in sperm counts and record-low fertility levels.

However, few investigators seem interested in assessing whether mumps outbreaks in highly vaccinated populations of teens and young adults could be having long-term effects on fertility or other health indicators.

As described in Part I, childhood MMR vaccination has been an unmitigated disaster where mumps is concerned, deferring mumps infection to older ages and leaving adolescents and young adults vulnerable to serious reproductive complications. Public health reports show that the vast majority of mumps cases and outbreaks occur in youth who have been fully vaccinated with the prescribed two-dose MMR series, supporting a hypothesis of “waning immunity after the second dose.” FDA and Centers for Disease Control and Prevention (CDC) officials even admit that mumps outbreaks in the post-vaccination era “typically involve young adults,” and that vaccination is failing to protect those who are college-age and above.

Myopically, many vaccine experts have called for a third MMR dose—or even “booster dosing throughout adulthood”—even though the FDA’s and CDC’s own research shows that MMR boosters in college-age youth barely last one year. As alleged in whistleblower lawsuits wending their way through the courts over the past eight years, Merck presented the FDA with a “falsely inflated efficacy rate” for the MMR’s mumps component, using animal antibodies and other fraudulent tactics to fool FDA—and the public—into believing that the vaccine was effective.


Have you heard about serious infections traced back to vaccinations in 3 states? Why not?

Mumps After Puberty is No Laughing Matter

Around the time that the first mumps vaccine came on the market, the 1967 children’s classic The Great Brain humorously depicted mumps infection in childhood as a mere nuisance. The book’s young protagonist goes out of his way to intentionally infect himself with mumps so that he can beat his two brothers to the recovery finish line—and he experiences no adverse consequences other than his siblings’ annoyance.

When infection arises after puberty, however, mumps is no laughing matter, presenting an increased risk of complications such as hearing loss, encephalitis and inflammation of the reproductive organs. About one in three postpubertal men with mumps develops orchitis(inflammation of the testes), which can damage sperm, affect testosterone production and contribute to subfertility and infertility. During a mumps outbreak in England in the mid-2000s, mumps orchitis accounted for 42% of all hospitalized mumps cases; the researchers attributed this outcome—which was the most common reason for hospitalization—to “the high attack rates in adolescents and young adults” that occurred “despite high coverage with two-dose MMR.” An analysis of a 2006 mumps outbreak in the U.S. reported that male patients were over three times more likely than female patients to experience complications, “due primarily to orchitis.”

Mumps infections are often asymptomatic or produce nonspecific symptoms such as fever, while cases of orchitis may present with no other mumps symptoms. Nonetheless, public health officials advise clinicians that orchitis is an instant cue to test for mumps virus, and testing often reveals elevated mumps antibodies. In a case report of MMR failure, British clinicians isolated a novel genetic strain of mumps virus from the patient’s semen two weeks after the onset of orchitis and found mumps RNA in the semen 40 days later; they also noted “the appearance of anti-sperm antibodies,” with “potential long-term adverse effects on the patient’s fertility.”

In 2017, researchers who reviewed 185 studies conducted in Western nations found that sperm counts had plummeted by 50% to 60% between 1973 and 2011—an average decrease of 1.4% annually. Commenting on this work, one analyst estimated that 20% to 30% of young men in Europe and North America have sperm concentrations associated with a reduced ability to father a child. Given estimates that as much as 40% of reproductive problems have to do with the male partner, there is agreement on the importance of “finding and eliminating [the] hidden culprits in the environment” that most researchers believe are to blame.

An estimated 5% to 10% of postpubertal women will develop oophoritis (swelling of the ovaries) following mumps infection. Oophoritis is associated with premature menopause and infertility, but mumps-related oophoritis has garnered little notice.

MMR’s and MMRV’s Potential to Impair Fertility Never Studied

Merck has not evaluated either of its two MMR vaccines—the MMR-II and the MMR-plus-varicella (MMRV) vaccine—for their potential to impair fertility. Whether such testing would unearth direct effects on fertility (as appears to be possible with HPV vaccination in women) is thus unknown. However, mumps vaccination undeniably increases reproductive-age individuals’ risk of mumps infection and, in the process, increases the risk of fertility-altering complications. These facts alone should be attracting far more attention.

Unfortunately, because clinicians already tend to underdiagnose mumps infection and underestimate mumps complications, it is likely that they are failing to recognize possible vaccine-induced reproductive health consequences of mumps infection in their adolescent and young adult patients. In one university outbreak, “most physicians…did not suspect mumps,” and even when they became aware of the outbreak, “diagnosing mumps was not always straightforward.” Moreover, although differentiating between vaccine strains of mumps virus and wild types could provide valuable information, few clinicians have the capacity or inclination to perform testing of this type. A Japanese study of cerebrospinal fluid and saliva from patients with mumps complications found vaccine strain in nearly all of the samples and noted the information’s importance in helping determine whether the complications were vaccine-related.

Those who have sought to understand mumps vaccines’ poor performance point to a mixture of explanatory factors. These include waning immunity, the high population density and close quarters encountered in settings such as college campuses, incomplete vaccine-induced immunity to wild virus as well as viral evolution such that “the vaccine triggers a less potent reaction against today’s mumps viruses than those of 50 years ago.” However, some also quietly admit that individuals with “mild vaccine-modified disease” could be perpetuating the chain of transmission. This latter point ought to be raising questions about the logic and wisdom of administering further rounds of MMR boosters during outbreaks while ignoring the problems created by the doses already given.

Most scientists appear to be either resigned to ongoing mumps outbreaks in vaccinated populations or actually accept periodic outbreaks as the cost of doing business. Publications by FDA and CDC researchers reveal these agencies’ awareness that some individuals respond poorly to mumps vaccination and that vaccine-induced antibody levels correlate poorly with protection from mumps infection, “irrespective of the number of additional doses of mumps-containing vaccine they receive.” Considering the effects on fertility, the generally abysmal track record of mumps vaccination and Merck’s fraudulent claims about efficacy, it is hard to fathom medical and public health experts’ complacency about current mumps vaccines and vaccine policies.

The viewpoints expressed here do not necessarily represent those of Infowars.


Sol Pais has been found dead in Colorado after Authorities were made aware of her intentions to possibly commit a mass shooting.

Source: InfoWars

0 0

Chicago to Sue Jussie Smollett After He Refuses to Pay For Police Overtime

Super Male Vitality

Limited Advanced Release

69.95

31.47

The all new and advanced Super Male Vitality formula uses the newest extraction technology with even more powerful concentrations of various herbs and extracts designed to be even stronger.

https://www.infowars.com/wp-content/uploads/2016/02/smv-200.jpg

https://www.infowarsstore.com/super-male-vitality.html?ims=jftqm&utm_campaign=IW+-+SuperMale+-STFA+-+55%25+Off+-+Widget&utm_source=Infowars+Widget&utm_medium=Widget&utm_content=IW-STFA-SuperMale-55%25off-Widget

https://www.infowarsstore.com/super-male-vitality.html?ims=jftqm&utm_campaign=IW+-+SuperMale+-STFA+-+55%25+Off+-+Widget&utm_source=Infowars+Widget&utm_medium=Widget&utm_content=IW-STFA-SuperMale-55%25off-Widget

Super Male Vitality

69.95

31.47

The all new and advanced Super Male Vitality formula uses the newest extraction technology with even more powerful concentrations of various herbs and extracts designed to be even stronger.

https://www.infowars.com/wp-content/uploads/2016/02/smv-200.jpg

https://www.infowarsstore.com/super-male-vitality.html?ims=jftqm&utm_campaign=IW+-+SuperMale+-STFA+-+55%25+Off+-+Widget&utm_source=Infowars+Widget&utm_medium=Widget&utm_content=IW-STFA-SuperMale-55%25off-Widget

https://www.infowarsstore.com/super-male-vitality.html?ims=jftqm&utm_campaign=IW+-+SuperMale+-STFA+-+55%25+Off+-+Widget&utm_source=Infowars+Widget&utm_medium=Widget&utm_content=IW-STFA-SuperMale-55%25off-Widget

Brain Force Plus

39.95

15.98

Flip the switch and supercharge your state of mind with the all-new Brain Force PLUS: 20% more capsules and a critically enhanced formula featuring a brand new ingredient and increased potency* – all for the same low price.

https://www.infowars.com/wp-content/uploads/2016/02/bf-300-1.jpg

https://www.infowarsstore.com/brain-force.html?ims=bnlem&utm_campaign=IW+-+Brain+Force+-STFA+-+60%25+Off+-+Widget&utm_source=Infowars+Widget&utm_medium=Widget&utm_content=IW-STFA-BrainForce-60%25off-Widget

https://www.infowarsstore.com/brain-force.html?ims=bnlem&utm_campaign=IW+-+Brain+Force+-STFA+-+60%25+Off+-+Widget&utm_source=Infowars+Widget&utm_medium=Widget&utm_content=IW-STFA-BrainForce-60%25off-Widget

DNA Force Plus

149.95

59.80

With one of our most advanced formulas yet, DNA Force Plus is finally here. Focusing on overhauling your body's cellular engines and protecting them from reactive oxygen species, DNA Force Plus has one of the best combinations of antioxidants on the market.

https://www.infowars.com/wp-content/uploads/2016/02/dna-210.jpg

https://www.infowarsstore.com/dna-force-plus.html?ims=xxqxg&utm_campaign=DNA+Force+Plus+-+STFA+Ending+Soon+-+60%25+Off+&utm_source=Infowars+Widget&utm_medium=Widget&utm_content=IW-DNAFP-Widget-60%25off-STFA

https://www.infowarsstore.com/dna-force-plus.html?ims=xxqxg&utm_campaign=DNA+Force+Plus+-+STFA+Ending+Soon+-+60%25+Off+&utm_source=Infowars+Widget&utm_medium=Widget&utm_content=IW-DNAFP-Widget-60%25off-STFA

DNA Force Plus

149.95

59.80

With one of our most advanced formulas yet, DNA Force Plus is finally here. Focusing on overhauling your body's cellular engines and protecting them from reactive oxygen species, DNA Force Plus has one of the best combinations of antioxidants on the market.

https://www.infowars.com/wp-content/uploads/2016/02/dna-210.jpg

https://www.infowarsstore.com/dna-force-plus.html?ims=xxqxg&utm_campaign=DNA+Force+Plus+-+STFA+Ending+Soon+-+60%25+Off+&utm_source=Infowars+Widget&utm_medium=Widget&utm_content=IW-DNAFP-Widget-60%25off-STFA

https://www.infowarsstore.com/dna-force-plus.html?ims=xxqxg&utm_campaign=DNA+Force+Plus+-+STFA+Ending+Soon+-+60%25+Off+&utm_source=Infowars+Widget&utm_medium=Widget&utm_content=IW-DNAFP-Widget-60%25off-STFA

DNA Force Plus

149.95

59.80

With one of our most advanced formulas yet, DNA Force Plus is finally here. Focusing on overhauling your body's cellular engines and protecting them from reactive oxygen species, DNA Force Plus has one of the best combinations of antioxidants on the market.

https://www.infowars.com/wp-content/uploads/2016/02/dna-210.jpg

https://www.infowarsstore.com/dna-force-plus.html?ims=xxqxg&utm_campaign=DNA+Force+Plus+-+STFA+Ending+Soon+-+60%25+Off+&utm_source=Infowars+Widget&utm_medium=Widget&utm_content=IW-DNAFP-Widget-60%25off-STFA

https://www.infowarsstore.com/dna-force-plus.html?ims=xxqxg&utm_campaign=DNA+Force+Plus+-+STFA+Ending+Soon+-+60%25+Off+&utm_source=Infowars+Widget&utm_medium=Widget&utm_content=IW-DNAFP-Widget-60%25off-STFA

Source: InfoWars

0 0

Nadler says Barr may miss Democrats’ April 2 deadline for Mueller report

U.S. Representative Nadler arrives for a House Democratic party caucus meeting at the U.S. Capitol in Washington
U.S. Representative Jerry Nadler (D-NY) arrives for a House Democratic party caucus meeting at the U.S. Capitol in Washington, U.S. January 9, 2019. REUTERS/Jonathan Ernst

March 27, 2019

WASHINGTON (Reuters) – U.S. House Judiciary Committee Chairman Jerry Nadler said on Wednesday he was very concerned that Attorney General William Barr will not submit Special Counsel Robert Mueller’s Russia report to Congress by April 2 as Democrats had requested.

Nadler also told reporters that Barr, who released a four-page summary on Sunday of Mueller’s investigation into Russian interference in the 2016 presidential election, would not commit to submitting the entire report to Congress.

Nadler, who said he had a 10-minute phone conversation on Wednesday with Barr, said the attorney general told him he had agreed to testify before the Judiciary Committee. Nadler left open the possibility that Mueller may testify sometime after Barr appears.

(Reporting by Richard Cowan; writing by Eric Beech; Editing by David Alexander)

Source: OANN

0 0

German Gov Split on Saudi Arms Ban

Germany’s government coalition is split on whether to maintain the ban on arms sales to Saudi Arabia in the face of increasing pressure on France.

The temporary embargo, imposed in November, is due to expire at the end of this week, but a meeting of the national security council (Chancellor Angela Merkel and her senior ministers) ended inconclusively on Wednesday, according to the DPA news agency.

The government parties, the Christian Democratic Union (CDU) and the Social Democratic Party (SPD), are to discuss the issue further. The SPD want to extend the ban: foreign policy spokesman Rolf Mützenich told the Bonn-based General Anzeiger that his party was insisting on the coalition contract, “which mean no more weapons exports to Saudi Arabia if they’re being used in the war in Yemen.”

During Wednesday’s regular government press conference, spokesman Steffen Seibert did not confirm DPA’s account and did not offer any details on the morning’s cabinet meeting, which was attended by French Foreign Minister Jean-Yves Le Drian as part of a new program of closer cooperation between the two countries.

Despite a barrage of questions from reporters, Seibert refused to say when the decision on the embargo would be made, other than to say there were ongoing “intensive discussions” within the government and with Paris, nor when and exactly how the decision would be made public.


Mohammed bin Salman was behind the Yemen War that has claimed the lives of over 13,000 including 3,000 children.

Diplomatic Problem

Germany stopped arms exports to Saudi Arabia last November in the wake of the murder of Saudi journalist Jamal Khashoggi in the country’s consulate in Turkey. At the time, Merkel said that no new exports to the country would be allowed until the circumstances of Khashoggi’s death had been established. But more recently, the chancellor indicated that Germany needed to be more flexible.

But the embargo has caused tensions with France, whose government is committed both to joint military projects with Germany as well as its arms deals with Riyadh, which has led to a diplomatic row between the two countries.

French Ambassador to Germany Anne-Marie Descotes weighed in on the discussion on Monday in an essay published by the German military’s Federal Academy for Security Policy, which complained about the “growing politicization” of Germany’s debate on arms exports.

Descotes warned that this debate would leave companies preferring “German-free arms products” — in other words, weapons systems that did not include German components. Descotes also admonished Germans for treating the debate as if weapons exports were a domestic policy matter, when in fact “it has serious consequences for our bilateral cooperation in the field of defense for the strengthening of European sovereignty.”

(Photo by fahd sadi / Wikimedia Commons)

Pointless Export Controls

The ambassador’s essay touches on the existential dilemma of the European arms industry: that the EU’s internal market is not big enough to sustain its massively expensive projects, though selling weapons beyond Europe means arming murderous repressive regimes involved in horrific wars.

In 2008, the European Council adopted a set of common rules defining the criteria for controlling arms exports. These included, “Respect for human rights in the recipient country and of international humanitarian law by that country.”

EU members states are obliged to deny an export license if “there is a clear risk that the military technology or equipment to be exported might be used for internal repression” and to assess on a case-by-case basis exports to countries where “serious violations of human rights” have been established by the United Nations, the EU, or the Council of Europe.

Saudi Arabia has continually been denounced for human rights abuses against regime opponents, not least the murder of Khashoggi, but also the punishment of Raif Badawi, who in 2014 was sentenced to 10 years in prison and 1,000 lashes for insulting Islam on his blog. Meanwhile, female activists have reported torture and sexual abuse in Saudi prisons.

Saudi Arabia is also been fighting an ongoing war in Yemen that has caused what the UN calls “the worst famine in 100 years,” which is leaving 13 million people facing starvation. Earlier this month investigations by DW and others revealed that German weapons are being used in Yemen, despite Germany’s export controls.

“The re-start of arms exports to Saudi Arabia would be a fatal foreign policy signal and would contribute to the continued destabilization of the Middle East,” Green party spokesman Omid Nouripour told DW. “We need a common European arms export policy that excludes exports into war zones.”


Paul Joseph Watson breaks down how Jewish-Australian activist and military veteran Avi Yemini has been banned from Facebook after publishing a video report that exposed ‘comedian’ Jim Jefferies and proved that he deceptively edited an interview with Yemini to deliberately change the meaning of his words.

Source: InfoWars

0 0

Erdogan says Turkey can’t quit S-400 missile deal with Russia

Turkish President Erdogan addresses his supporters during a rally for the upcoming local elections, in Istanbul,
Turkish President Tayyip Erdogan addresses his supporters during a rally for the upcoming local elections, in Istanbul, Turkey March 12, 2019. REUTERS/Murad Sezer

March 14, 2019

ISTANBUL (Reuters) – It is not possible for Turkey to back out of a deal with Russia to buy S-400 missile defense systems, President Tayyip Erdogan said on Thursday.

He made the comment in an interview with private broadcaster Haberturk. Asked whether it is possible for Turkey to buy the S-400s but not activate them, Erdogan said that was not possible.

Washington has warned that procuring the S-400 systems from Russia could jeopardize defense industry deals between the NATO allies.

(Reporting by Ali Kucukgocmen; Editing by Robin Pomeroy)

Source: OANN

0 0

Darling stands by slur allegation against Dykstra

FILE PHOTO: Former Mets' pitcher Darling waves to crowd before throwing out ceremonial first pitch at Game 7 in the Mets' NLCS playoff baseball series against the Cardinals in New York
FILE PHOTO: Former New York Mets' pitcher Ron Darling waves to the crowd before throwing out the ceremonial first pitch at Game 7 in the Mets' NLCS playoff baseball series against the St. Louis Cardinals in New York October 19, 2006. REUTERS/Mike Segar

April 2, 2019

Former New York Mets pitcher Ron Darling on Tuesday stood by the allegation he made in his new book that Lenny Dykstra shouted racial slurs at a Boston Red Sox pitcher in the 1986 World Series.

Darling went on the ESPN radio show “Golic and Wingo” to reassert his claim that Dykstra, his former teammate, hurled racial insults at Dennis “Oil Can” Boyd prior to his first at-bat of Game 3 of the World Series.

“I heard what I heard and I put it in the book for a reason,” Darling said, referring to his new book titled, “108 Stitches: Loose Threads, Ripping Yarns, and the Darndest Characters from My Time in the Game.”

In the book, released Tuesday, Darling wrote that Dykstra was “shouting every imaginable and unimaginable insult and expletive in his [Boyd’s] direction — foul, racist, hateful, hurtful stuff” while in the on-deck circle. Further, Darling wrote that the insults were “worse than anything Jackie Robinson might have heard.”

For his part, Dykstra went on ESPN Radio’s “Michael Kay Show” on Monday and threatened to sue Darling. Further, Dwight Gooden and Kevin Mitchell told Kay on Monday that they never heard Dykstra slur Boyd.

But Darling said Tuesday that there’s “no chance that I misremembered it.”

–Field Level Media

Source: OANN

0 0

Related to buy AT&T’s WarnerMedia headquarters for $2.2 billion

FILE PHOTO: 'The Vessel,' a large public art sculpture made up of 155 flights of stairs, is seen at the center of The Hudson Yards development, in New York
FILE PHOTO: The Hudson Yards development, a residential, commercial, and retail space on Manhattan's West side, during the grand opening in New York City, New York, U.S., March 15, 2019. REUTERS/Brendan McDermid/File Photo

April 24, 2019

By Herbert Lash

NEW YORK (Reuters) – Developer Related Companies said on Tuesday one of its affiliates has agreed to buy the global headquarters of AT&T’s WarnerMedia in Manhattan for about $2.2 billion, in one of the city’s most expensive commercial real estate deals.

The affiliate has entered into a contract expected to close late in the second quarter for WarnerMedia’s offices spanning 26 floors at 30 Hudson Yards, Related said in a statement.

Related will enter into a long-term lease-back until early 2034 for the space of about 1.5 million square feet (139,355 meters) in an office tower that has the highest observation deck in the Western Hemisphere.

Hudson Yards is a new $25 billion complex of commercial and residential skyscrapers built on Manhattan’s far west side above the rail yards.

Related won bidding to buy WarnerMedia’s stake, as Reuters reported earlier this month. WarnerMedia, formerly Time Warner, became a partner in the building’s development in 2014.

AT&T has sought to cut its debt by about $20 billion in 2019 after last year’s $85 billion takeover of Time Warner.

A team led by Doug Harmon at brokerage Cushman & Wakefield represented WarnerMedia in the transaction, the most expensive in Manhattan since the sale of Chelsea Market to Alphabet Inc’s Google last year for $2.4 billion in a deal Harmon also handled.

(This story corrects last paragraph to say WarnerMedia, not Related)

(Reporting by Herbert Lash; Editing by Leslie Adler)

Source: OANN

NOW ON AIR
Now On Air

Story Time

1:00 am 6:00 am



The Wider Image: China's start-ups go small in age of 'shoebox' satellites
LinkSpace’s reusable rocket RLV-T5, also known as NewLine Baby, is carried to a vacant plot of land for a test launch in Longkou, Shandong province, China, April 19, 2019. REUTERS/Jason Lee

April 26, 2019

By Ryan Woo

LONGKOU, China (Reuters) – During initial tests of their 8.1-metre (27-foot) tall reusable rocket, Chinese engineers from LinkSpace, a start-up led by China’s youngest space entrepreneur, used a Kevlar tether to ensure its safe return. Just in case.

But when the Beijing-based company’s prototype, called NewLine Baby, successfully took off and landed last week for the second time in two months, no tether was needed.

The 1.5-tonne rocket hovered 40 meters above the ground before descending back to its concrete launch pad after 30 seconds, to the relief of 26-year-old chief executive Hu Zhenyu and his engineers – one of whom cartwheeled his way to the launch pad in delight.

LinkSpace, one of China’s 15-plus private rocket manufacturers, sees these short hops as the first steps towards a new business model: sending tiny, inexpensive satellites into orbit at affordable prices.

Demand for these so-called nanosatellites – which weigh less than 10 kilograms (22 pounds) and are in some cases as small as a shoebox – is expected to explode in the next few years. And China’s rocket entrepreneurs reckon there is no better place to develop inexpensive launch vehicles than their home country.

“For suborbital clients, their focus will be on scientific research and some commercial uses. After entering orbit, the near-term focus (of clients) will certainly be on satellites,” Hu said.

In the near term, China envisions massive constellations of commercial satellites that can offer services ranging from high-speed internet for aircraft to tracking coal shipments. Universities conducting experiments and companies looking to offer remote-sensing and communication services are among the potential domestic customers for nanosatellites.

A handful of U.S. small-rocket companies are also developing launchers ahead of the expected boom. One of the biggest, Rocket Lab, has already put 25 satellites in orbit.

No private company in China has done that yet. Since October, two – LandSpace and OneSpace – have tried but failed, illustrating the difficulties facing space start-ups everywhere.

The Chinese companies are approaching inexpensive launches in different ways. Some, like OneSpace, are designing cheap, disposable boosters. LinkSpace’s Hu aspires to build reusable rockets that return to Earth after delivering their payload, much like the Falcon 9 rockets of Elon Musk’s SpaceX.

“If you’re a small company and you can only build a very, very small rocket because that’s all you have money for, then your profit margins are going to be narrower,” said Macro Caceres, analyst at U.S. aerospace consultancy Teal Group.

“But if you can take that small rocket and make it reusable, and you can launch it once a week, four times a month, 50 times a year, then with more volume, your profit increases,” Caceres added.

Eventually LinkSpace hopes to charge no more than 30 million yuan ($4.48 million) per launch, Hu told Reuters.

That is a fraction of the $25 million to $30 million needed for a launch on a Northrop Grumman Innovation Systems Pegasus, a commonly used small rocket. The Pegasus is launched from a high-flying aircraft and is not reusable.

(Click https://reut.rs/2UVBjKs to see a picture package of China’s rocket start-ups. Click https://tmsnrt.rs/2GIy9Bc for an interactive look at the nascent industry.)

NEED FOR CASH

LinkSpace plans to conduct suborbital launch tests using a bigger recoverable rocket in the first half of 2020, reaching altitudes of at least 100 kilometers, then an orbital launch in 2021, Hu told Reuters.

The company is in its third round of fundraising and wants to raise up to 100 million yuan, Hu said. It had secured tens of millions of yuan in previous rounds.

After a surge in fresh funding in 2018, firms like LinkSpace are pushing out prototypes, planning more tests and even proposing operational launches this year.

Last year, equity investment in China’s space start-ups reached 3.57 billion yuan ($533 million), a report by Beijing-based investor FutureAerospace shows, with a burst of financing in late 2018.

That accounted for about 18 percent of global space start-up investments in 2018, a historic high, according to Reuters calculations based on a global estimate by Space Angels. The New York-based venture capital firm said global space start-up investments totaled $2.97 billion last year.

“Costs for rocket companies are relatively high, but as to how much funding they need, be it in the hundreds of millions, or tens of millions, or even just a few million yuan, depends on the company’s stage of development,” said Niu Min, founder of FutureAerospace.

FutureAerospace has invested tens of millions of yuan in LandSpace, based in Beijing.

Like space-launch startups elsewhere in the world, the immediate challenge for Chinese entrepreneurs is developing a safe and reliable rocket.

Proven talent to develop such hardware can be found in China’s state research institutes or the military; the government directly supports private firms by allowing them to launch from military-controlled facilities.

But it’s still a high-risk business, and one unsuccessful launch might kill a company.

“The biggest problem facing all commercial space companies, especially early-stage entrepreneurs, is failure” of an attempted flight, Liang Jianjun, chief executive of rocket company Space Trek, told Reuters. That can affect financing, research, manufacturing and the team’s morale, he added.

Space Trek is planning its first suborbital launch by the end of June and an orbital launch next year, said Liang, who founded the company in late 2017 with three other former military technical officers.

Despite LandSpace’s failed Zhuque-1 orbital launch in October, the Beijing-based firm secured 300 million yuan in additional funding for the development of its Zhuque-2 rocket a month later.

In December, the company started operating China’s first private rocket production facility in Zhejiang province, in anticipation of large-scale manufacturing of its Zhuque-2, which it expects to unveil next year.

STATE COMPETITION

China’s state defense contractors are also trying to get into the low-cost market.

In December, the China Aerospace Science and Industry Corp (CASIC) successfully launched a low-orbit communication satellite, the first of 156 that CASIC aims to deploy by 2022 to provide more stable broadband connectivity to rural China and eventually developing countries.

The satellite, Hongyun-1, was launched on a rocket supplied by the China Aerospace Science and Technology Corp (CASC), the nation’s main space contractor.

In early April, the China Academy of Launch Vehicle Technology (CALVT), a subsidiary of CASC, completed engine tests for its Dragon, China’s first rocket meant solely for commercial use, clearing the path for a maiden flight before July.

The Dragon, much bigger than the rockets being developed by private firms, is designed to carry multiple commercial satellites.

At least 35 private Chinese companies are working to produce more satellites.

Spacety, a satellite maker based in southern Hunan province, plans to put 20 satellites in orbit this year, including its first for a foreign client, chief executive Yang Feng told Reuters.

The company has only launched 12 on state-produced rockets since the company started operating in early 2016.

“When it comes to rocket launches, what we care about would be cost, reliability and time,” Yang said.

(Reporting by Ryan Woo; Additional reporting by Beijing newsroom; Editing by Gerry Doyle)

Source: OANN

Listen to https://magaoneradio.net and Listen Daily! Don't Forget to Share Click a Link Below!
German drug and crop chemical maker Bayer holds annual general meeting
Werner Baumann, CEO of German pharmaceutical and chemical maker Bayer AG, attends the annual general shareholders meeting in Bonn, Germany, April 26, 2019. REUTERS/Wolfgang Rattay

April 26, 2019

By Patricia Weiss and Ludwig Burger

BONN (Reuters) – Bayer shareholders vented their anger over its stock price slump on Friday as litigation risks mount from the German drugmaker’s $63 billion takeover of seed maker Monsanto.

Several large investors said they will not support aspirin investor Bayer’s management in a key vote scheduled for the end of its annual general meeting.

Bayer’s management, led by chief executive Werner Baumann, could see an embarrassing plunge in approval ratings, down from 97 percent at last year’s AGM, which was held shortly before the Monsanto takeover closed in June.

A vote to ratify the board’s actions features prominently at every German AGM. Although it has no bearing on management’s liability, it is seen as a key gauge of shareholder sentiment.

“Due to the continued negative development at Bayer, high legal risks and a massive share price slump, we refuse to ratify the management board and supervisory board’s actions during the business year,” Janne Werning, representing Germany’s Union Investment, a top-20 shareholder, said in prepared remarks.

About 30 billion euros ($34 billion) have been wiped off Bayer’s market value since August, when a U.S. jury found the pesticide and drugs group liable because Monsanto had not warned of alleged cancer risks linked to its weedkiller Roundup.

Bayer suffered a similar defeat last month and more than 13,000 plaintiffs are claiming damages.

Bayer is appealing or plans to appeal the verdicts.

Deutsche Bank’s asset managing arm DWS said shareholders should have been consulted before the takeover, which was agreed in 2016 and closed in June last year.

“You are pointing out that the lawsuits have not been lost yet. We and our customers, however, have already lost something – money and trust,” Nicolas Huber, head of corporate governance at DWS, said in prepared remarks for the AGM.

He said DWS would abstain from the shareholder vote of confidence in the executive and non-executive boards.

Two people familiar with the situation told Reuters this week that Bayer’s largest shareholder, BlackRock, plans to either abstain from or vote against ratifying the management board’s actions.

Asset management firm Deka, among Bayer’s largest German investors, has also said it would cast a no vote.

Baumann said Bayer’s true value was not reflected in the current share price.

“There’s no way to make this look good. The lawsuits and the first verdicts weigh heavily on our company and it’s a concern for many people,” he said, adding it was the right decision to buy Monsanto and that Bayer was vigorously defending itself.

This month, shareholder advisory firms Institutional Shareholder Services (ISS) and Glass Lewis recommended investors not to give the executive board their seal of approval.

(Reporting by Patricia Weiss and Ludwig Burger; Editing by Alexander Smith)

Source: OANN

Listen to https://magaoneradio.net and Listen Daily! Don't Forget to Share Click a Link Below!

Sudan’s military, which ousted President Omar al-Bashir after months of protests against his 30-year rule, says it intends to keep the upper hand during the country’s transitional period to civilian rule.

The announcement is expected to raise tensions with the protesters, who demand immediate handover of power.

The Sudanese Professionals Association, which is spearheading the protests, said Friday the crowds will stay in the streets until all their demands are met.

Shams al-Deen al-Kabashi, the spokesman for the military council, said late Thursday that the military will “maintain sovereign powers” while the Cabinet would be in the hands of civilians.

The protesters insist the country should be led by a “civilian sovereign” council with “limited military representation” during the transitional period.

The army toppled and arrested al-Bashir on April 11.

Source: Fox News World

Listen to https://magaoneradio.net and Listen Daily! Don't Forget to Share Click a Link Below!
FILE PHOTO: Small toy figures are seen in front of a displayed Huawei and 5G network logo in this illustration picture
FILE PHOTO: Small toy figures are seen in front of a displayed Huawei and 5G network logo in this illustration picture, March 30, 2019. REUTERS/Dado Ruvic

April 26, 2019

By Charlotte Greenfield

WELLINGTON (Reuters) – China’s Huawei Technologies said Britain’s decision to allow the firm a restricted role in building parts of its next-generation telecoms network was the kind of solution it was hoping for in New Zealand, where it has been blocked from 5G plans.

Britain will ban Huawei from all core parts of 5G network but give it some access to non-core parts, sources have told Reuters, as it seeks a middle way in a bitter U.S.-China dispute stemming from American allegations that Huawei’s equipment could be used by Beijing for espionage.

Washington has also urged its allies to ban Huawei from building 5G networks, even as the Chinese company, the world’s top producer of telecoms equipment, has repeatedly said the spying concerns are unfounded.

In New Zealand, a member of the Five Eyes intelligence sharing network that includes the United States, the Government Communications Security Bureau (GCSB) in November turned down an initial request from local telecommunication firm Spark to include Huawei equipment in its 5G network, but later gave the operator options to mitigate national security concerns.

“The proposed solution in the UK to restrict Huawei from bidding for the core is exactly the type of solution we have been looking at in New Zealand,” Andrew Bowater, deputy CEO of Huawei’s New Zealand arm, said in an emailed statement.

Spark said it has noted the developments in Britain and would raise it with the GCSB.

The reports “suggest the UK is following other European jurisdictions in taking a considered and balanced approach to managing supplier-related security risks in 5G”, Andrew Pirie, Spark’s corporate relations lead, said in an email.

“Our discussions with the GCSB are ongoing and we expect that the UK developments will be a further item of discussion between us,” Pirie added.

New Zealand’s minister for intelligence services, Andrew Little, did not immediately respond to a request for comment.

British culture minister Jeremy Wright said on Thursday that he would report to parliament the conclusions of a government review of the 5G supply chain once they had been taken.

He added that the disclosure of confidential discussions on the role of Huawei was “unacceptable” and that he could not rule out a criminal investigation into the leak.

The decisions by Britain and Germany to use Huawei gear in non-core parts of 5G network makes it harder to prove Huawei should be kept out of New Zealand telecommunication networks, said Syed Faraz Hasan, an expert in communication engineering and networks at New Zealand’s Massey University

He pointed out Huawei gear was already part of the non-core 4G networks that 5G infrastructure would be built on.

“Unless there is a convincing argument against the Huawei devices … it is difficult to keep them away,” Hasan said.

(Reporting by Charlotte Greenfield; Editing by Himani Sarkar)

Source: OANN

Listen to https://magaoneradio.net and Listen Daily! Don't Forget to Share Click a Link Below!
FILE PHOTO: The logo commodities trader Glencore is pictured in Baar
FILE PHOTO: The logo of commodities trader Glencore is pictured in front of the company’s headquarters in Baar, Switzerland, July 18, 2017. REUTERS/Arnd Wiegmann

April 26, 2019

(Reuters) – Glencore shares plunged the most in nearly four months on Friday after news overnight that U.S. regulators were investigating whether the miner broke some rules through “corrupt practices”.

Shares of the FTSE 100 company fell as much as 4.2 percent in early deals, and were down 3.5 percent at 310.25 pence by 0728 GMT.

On Thursday, Glencore said the U.S. Commodity Futures Trading Commission is investigating whether the company and its units have violated some provisions of the Commodity ExchangeAct and/or CFTC Regulations.

(Reporting by Muvija M in Bengaluru)

Source: OANN

Listen to https://magaoneradio.net and Listen Daily! Don't Forget to Share Click a Link Below!

Listen to https://magaoneradio.net and Listen Daily! Don't Forget to Share Click a Link Below!
Current track

Title

Artist